Category: News

Adam S. Kibel, MD, has been appointed the Elliott Carr Cutler Professor of Surgery in Urology at Harvard Medical School.

Adam S. Kibel, MD
Chief of Urology, Brigham and Women’s Hospital and Dana-Farber/Brigham and Women’s Cancer Center
Elliott Carr Cutler Professor of Surgery in Urology, Harvard Medical School

Adam S. Kibel, MD, is chief of Urology at Brigham and Women’s Hospital and Dana-Farber/Brigham and Women’s Cancer Center. He is the Elliot Carr Cutler Professor of Surgery in Urology at Harvard Medical School and serves as chairman of the Harvard Program in Urology (Longwood). Dr. Kibel received his undergraduate and medical degrees from Cornell University, completed a residency at the Harvard Urology Program and a fellowship at the Brady Urologic Institute at Johns Hopkins.

With a practice focused on minimally invasive treatments for urologic cancers, Dr. Kibel has been listed as one of America’s Top Doctors by Castle Connolly and named a top urologist by Boston Magazine. The author of over 250 peer-reviewed publications, Dr. Kibel’s research focuses on the identification of molecular markers of urologic tumors, adjuvant and neoadjuvant approaches to treatment of aggressive disease, and improved imaging of patients with urologic malignancies. His research has been supported by the National Cancer Institute, Department of Defense, American Cancer Society, American College of Surgeons and the American Foundation for Urologic Disease.

Simon G. Talbot, MD, has been awarded a $1M Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) Reconstructive Transplant Research Program (RTRP) grant to study the psychosocial predictors of outcomes in Vascularized Composite Allotransplant (VCA) patients.

Dr. Talbot will serve as the primary investigator on the multidisciplinary study “Psychosocial Predictors in VCA”, in partnership with co-investigators from the Department of Psychiatry – Sejal Shah, MD and Robert Edwards, PhD; the Orthopaedic and Arthritis Center for Outcomes Research (OrACORe) – Jeffrey N. Katz, MD, MSc and Elena Losina, PhD; Division of Plastic and Reconstructive Surgery – Matthew J. Carty, MD; and Department of Orthopaedic Surgery – George S. Dyer, MD.

Simon G. Talbot, MD
Associate Surgeon, Division of Plastic and Reconstructive Surgery, Brigham and Women’s Hospital
Director, Upper Extremity Transplant Program, Brigham and Women’s Hospital
Associate Professor of Surgery, Harvard Medical School

Simon G. Talbot, MD, specializes in general plastic surgery, hand surgery and microsurgery. In addition, he is an attending physician in the Brigham and Women’s Hospital Burn Center and the surgical lead in the Hand Transplant Program.

His research involves neurologic regeneration and rehabilitation in the upper extremity. Collaborating with the Harvard School of Engineering and Applied Science, he is helping make important contributions to the fields of hand surgery, reconstruction, transplantation and rehabilitation.

Nathaniel Treister, DMD, DMSc, Stephen Sonis, DMD, DMSc, and Sook-Bin Woo, DMD, MMSc, of the Division of Oral Medicine, were included in Boston magazine’s inaugural “Top Dentists 2017” list.

The three BWH Oral Medicine specialists, all board-certified in oral medicine, were among 381 dentists and dental specialists recognized on the list. Honorees were selected by their peers, with more than 600 dentists in Greater Boston completing the magazine’s online survey during the nomination period.

 

Treister is chief of the Division of Oral Medicine and Dentistry. His primary clinical interests include oral mucosal diseases and oral complications of cancer therapy and, in particular, graft-versus-host disease. As an investigator, he studies oral complications related to cancer therapies, with particular interest in hematopoietic cell transplantation, mucositis and graft-versus-host disease.

 

Sonis, former chief of the division, has clinical interests in oral mucosal diseases and regimen-related toxicities of cancer therapy. He is actively involved in translational and clinical research in the areas of supportive cancer care, radiation injury and genomics.

 

Woo, who is also board-certified in oral pathology, has clinical interests in oral lesions, oral mucosal diseases, cancer therapy and bisphosphonate-associated osteonecrosis (a form of bone disease that affects the jaw).